Patient Satisfaction Following Intrathecal Targeted Drug Delivery for Benign Chronic Pain: Results of a Single-Center Survey Study.

David M SchultzVwaire OrhurhuFaizan KhanJonathan M Hagedorn Alaa Abd-Elsayed

Published in: Neuromodulation : journal of the International Neuromodulation Society (2020)

Intrathecal TDD therapy can relieve pain and improve quality of life in patients with intractable pain and offers a reasonable alternative to long-term oral or skin patch opioid management. Patients utilizing TDD therapy reported high degrees of satisfaction.

Keyphrases

chronic pain
pain management
patient satisfaction
drug delivery
end stage renal disease
ejection fraction
newly diagnosed
cancer therapy
prognostic factors
peritoneal dialysis
neuropathic pain
bone marrow
mesenchymal stem cells
wound healing
drug release